Investments
12Portfolio Exits
3About Yuan Capital
Yuan Capital (乾源资本) is a private equity firm with offices in Beijing and Hong Kong. It focuses on world-class investment opportunities with a strong emphasis on China. Founded by seasoned investors and renowned business leaders from China, Yuan Capital leverages its deep expertise and network to help companies worldwide become successful in the region. It has invested in many leading players in a variety of sectors including technology, healthcare and finance.
Want to inform investors similar to Yuan Capital about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Yuan Capital News
Nov 22, 2018
China: Leap Motor receives 2 billion Yuan capital The Chinese electric vehicle startup Leap Motor has generated a total of 2 billion yuan (250 million euros) in their most recent financing round. They may even reach 2.5 billion yuan by the end of the year, with the Shanghai Electric Group leading the way. The capital will be invested in research and development, batteries, electric motors and support of marketing activities. The Hangzhou based company further confirmed that their electric Coupé LP-S01 will be available in January 2019. Their vehicle features a 125 kW electric motor and can reach a range of about 360 km with a single battery charge. A year ago, it was announced that the vehicle would be available in March 2019 with a price of about 26,000 euros, before subventions. As Leap Motor has not updated the details, we will assume that they still apply. In Jinhua in the province Zhejiang, Leap Motor is currently building a factory with a planned production capacity of 250,000 EVs per year. It is planned to be completed in the first quarter of 2019.
Yuan Capital Investments
12 Investments
Yuan Capital has made 12 investments. Their latest investment was in Eureka Therapeutics as part of their Series C - II on May 5, 2017.
Yuan Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
5/30/2017 | Series C - II | Eureka Therapeutics | $5.57M | No | 1 | |
4/22/2016 | Series B | Xiaoma Gouche | $15M | No | 1 | |
7/29/2015 | Series E | Radius Intelligence | $50M | No | 7 | |
7/27/2015 | Series E | |||||
3/30/2015 | Series C |
Date | 5/30/2017 | 4/22/2016 | 7/29/2015 | 7/27/2015 | 3/30/2015 |
|---|---|---|---|---|---|
Round | Series C - II | Series B | Series E | Series E | Series C |
Company | Eureka Therapeutics | Xiaoma Gouche | Radius Intelligence | ||
Amount | $5.57M | $15M | $50M | ||
New? | No | No | No | ||
Co-Investors | |||||
Sources | 1 | 1 | 7 |
Yuan Capital Portfolio Exits
3 Portfolio Exits
Yuan Capital has 3 portfolio exits. Their latest portfolio exit was Kabbage on August 17, 2020.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
8/17/2020 | Acquired | 19 | |||
Date | 8/17/2020 | ||
|---|---|---|---|
Exit | Acquired | ||
Companies | |||
Valuation | |||
Acquirer | |||
Sources | 19 |
Yuan Capital Team
1 Team Member
Yuan Capital has 1 team member, including former Managing Director, Jeffrey Ren.
Name | Work History | Title | Status |
|---|---|---|---|
Jeffrey Ren | Managing Director | Former |
Name | Jeffrey Ren |
|---|---|
Work History | |
Title | Managing Director |
Status | Former |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.